nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-1304Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESЛегочные инфекции у пациентов с почечным трансплантатомLung infections in renal transplant recipientsПрокопенкоЕ. И.ProkopenkoE. I.linkor@telios.ruМосковский областной научно-исследовательский клинический институт им. М.Ф. Владимирского, г. МоскваRussian Federation200819062025101615Copyright © Прокопенко Е.И., 20252025Прокопенко Е.И.Prokopenko E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/1304

Инфекции являются важной проблемой клинической трансплантологии. Установлено, что в течение первого года после трансплантации почки (ТП) среди всех фатальных осложнений инфекции наиболее значимы, и доля их составляет примерно 35%. В последующем инфекционные осложнения отступают на второе место после сердечно-сосудистых, но продолжают оставаться важнейшей причиной заболеваемости и летальности больных с трансплантированной почкой. Легочные инфекции (в том числе, системные инфекции с поражением легких) составляют почти половину летальных инфекционных осложнений у реципиентов ренального трансплантата.

трансплантация почкииммуносупрессиялегочные инфекцииReferencesРуководство по трансплантации почки. Под ред. Данович Г.М., пер. с англ. под ред. Мойсюка Я.Г. 3-е изд. Тверь: Триада 2004: 472 с.Руководство по трансплантации почки. Под ред. Данович Г.М., пер. с англ. под ред. Мойсюка Я.Г. 3-е изд. Тверь: Триада 2004: 472 с.Сергеев А.Ю., Сергеев Ю.В. Грибковые инфекции. Руководство для врачей. Москва: Бином-пресс 2003: 440 с.Сергеев А.Ю., Сергеев Ю.В. Грибковые инфекции. Руководство для врачей. Москва: Бином-пресс 2003: 440 с.Altiparmak M.R., Apaydin S., Trablus S. Systemic fungal infections after renal transplantation. Scand J Infect Dis 2002; 34 (4): 284-288.Altiparmak M.R., Apaydin S., Trablus S. Systemic fungal infections after renal transplantation. Scand J Infect Dis 2002; 34 (4): 284-288.Asberg A., Humar A., Rollag H. et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7: 2106-2113.Asberg A., Humar A., Rollag H. et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7: 2106-2113.Chang G.C., Wu C.L., Pan S.H. et al. The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures. Chest 2004; 125: 541-547.Chang G.C., Wu C.L., Pan S.H. et al. The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures. Chest 2004; 125: 541-547.EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002; 17 (Suppl. 4): 39-43.EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002; 17 (Suppl. 4): 39-43.Emery V. Facing the facts: the indirect effects of cytomegalovirus. Suppl. To Transplantation 2007; 84 (6S): S7-S10.Emery V. Facing the facts: the indirect effects of cytomegalovirus. Suppl. To Transplantation 2007; 84 (6S): S7-S10.Fishman J.A., Emery V., Freeman R. et al. Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant 2007; 21. DOI: 10.1111/j. 1399-0012. 2006. 00618. x.Fishman J.A., Emery V., Freeman R. et al. Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant 2007; 21. DOI: 10.1111/j. 1399-0012. 2006. 00618. x.Humar A., Michaels M. American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262-274.Humar A., Michaels M. American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262-274.Humar A. Cytomegalovirus prevention: prophylaxis and preemptive therapy. Suppl. To Transplantation 2007; 84 (6S): S11-S14.Humar A. Cytomegalovirus prevention: prophylaxis and preemptive therapy. Suppl. To Transplantation 2007; 84 (6S): S11-S14.de Pauw B.E., Rubin R.H. Individualization in the management of fungal disease in the transplant recipient. Transplant Infect Dis 2007; 9: 87-88.de Pauw B.E., Rubin R.H. Individualization in the management of fungal disease in the transplant recipient. Transplant Infect Dis 2007; 9: 87-88.Pescovitz M.D. Valganciclovir: What is the status in solid organ transplanrarion? Future Virol 2006; 1 (2): 147-156.Pescovitz M.D. Valganciclovir: What is the status in solid organ transplanrarion? Future Virol 2006; 1 (2): 147-156.Ram R., Swarnalatha G., Prasad N. et al. Tuberculosis in renal transplant recipients. Transplant Infect Dis 2007; 9: 97-101.Ram R., Swarnalatha G., Prasad N. et al. Tuberculosis in renal transplant recipients. Transplant Infect Dis 2007; 9: 97-101.Ravi Shankar M.S., Aravindan A.N., Sohal P.M. et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005; 20: 2720-2724.Ravi Shankar M.S., Aravindan A.N., Sohal P.M. et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005; 20: 2720-2724.Rubin R.H. Infection in the organ transplant patient. In: Rubin R.H., Young L.S., eds. Clinical approach to infection in the compromised host. New York: Plenum 1994: 629-669.Rubin R.H. Infection in the organ transplant patient. In: Rubin R.H., Young L.S., eds. Clinical approach to infection in the compromised host. New York: Plenum 1994: 629-669.Templeton K.E., Scheltinga S.A., Graffelman A.W. et al. Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol 2003; 41 (9): 4366-4371.Templeton K.E., Scheltinga S.A., Graffelman A.W. et al. Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol 2003; 41 (9): 4366-4371.

The authors declare that there are no conflicts of interest present.